NASDAQ: SXTP60 Degrees Pharmaceuticals Inc Stock Ownership - Who owns 60 Degrees Pharmaceuticals?
Insider buying vs selling
Have 60 Degrees Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Geoffrey S. Dow | President and CEO | 2025-12-15 | 9,670 | $0.80 | $7.76kBuy |
| Geoffrey S. Dow | President and CEO | 2025-12-11 | 3,613 | $0.92 | $3.32kBuy |
| Geoffrey S. Dow | President and CEO | 2025-12-10 | 9,350 | $0.95 | $8.88kBuy |
| Geoffrey S. Dow | President and CEO | 2025-09-12 | 7,201 | $1.39 | $9.99kBuy |
| Geoffrey S. Dow | President and CEO | 2025-06-09 | 4,376 | $2.99 | $13.07kBuy |
| Cheryl Xu | Director | 2025-06-03 | 3,000 | $2.87 | $8.61kBuy |
| Cheryl Xu | Director | 2025-06-03 | 2,000 | $2.90 | $5.80kBuy |
SXTP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SXTP insiders and whales buy or sell their stock.
SXTP Shareholders
What type of owners hold 60 Degrees Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Knight Therapeutics Inc | 45.02% | 1,187,140 | $1.75M | Insider |
| Geoffrey S. Dow | 27.98% | 737,880 | $1.08M | Insider |
| Kentucky Technology Inc | 19.91% | 525,000 | $771.75k | Insider |
| Florida State University Research Foundation Inc | 15.36% | 405,000 | $595.35k | Insider |
| Tyrone Miller | 1.00% | 26,370 | $38.76k | Insider |
| Jane Street Group LLC | 0.84% | 22,051 | $32.41k | Institution |
| Cheryl Xu | 0.60% | 15,816 | $23.25k | Insider |
| Stephen Toovey | 0.53% | 14,000 | $20.58k | Insider |
| Paul Field | 0.53% | 14,000 | $20.58k | Insider |
| Charles W. Allen | 0.53% | 14,000 | $20.58k | Insider |
SXTP vs Biotech Stocks
60 Degrees Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.